fda warning letter hims compounded semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Sends Warning Letters to

It can also contribute to constipation since digestion slows down overall

Understanding when compounded semaglutide expires prevents you from using degraded product

Preclinical research has demonstrated that GLP-1 receptor activation may confer neuroprotective effects through multiple mechanisms

For substantial weight loss, higher doses are often more effective

The 2023 NEEL gel IRB study reported an average 28% increase in skin collagen density at 3 months

Research on adaptive thermogenesis shows that individuals who lose substantial weight experience metabolic adaptations where the body becomes more energy-efficient and generates less heat relative to body size